| BIOMEDICAL ENGINEERING | |||||
| Bachelor | TR-NQF-HE: Level 6 | QF-EHEA: First Cycle | EQF-LLL: Level 6 | ||
| Course Code | Course Name | Semester | Theoretical | Practical | Credit | ECTS |
| IF4420 | Mergers and Acquisitions | Spring | 3 | 0 | 3 | 9 |
| This catalog is for information purposes. Course status is determined by the relevant department at the beginning of semester. |
| Language of instruction: | English |
| Type of course: | Non-Departmental Elective |
| Course Level: | Bachelor’s Degree (First Cycle) |
| Mode of Delivery: | Face to face |
| Course Coordinator : | Dr. Öğr. Üyesi BAHAR KÖSEOĞLU |
| Course Lecturer(s): |
Dr. Öğr. Üyesi UMUT UĞURLU Prof. Dr. İPEK ALTINBAŞAK FARİNA |
| Recommended Optional Program Components: | None |
| Course Objectives: | This course aims at providing students an analytical and theoretical framework to understand the M&A process and will also use cases and real-world applications to develop skills necessary to evaluate and implement a transaction. |
|
The students who have succeeded in this course; The student who successfully completes this course; I. will have a thorough knowledge of the value drivers of a company II.Will be able to assess a company within the context of its competitive advantage and the industry it operates in III.Will learn the process of M&A of a company IV.Will know the difference of the M&A process from the buyer or seller perspectives V.Be able to do basic company valuation VI Have an insight to the participants of the M&A process, negotiation process and the legal documents involved in M&A process. |
| Valuation, valuation techniques, M&A process, Negotiations |
| Week | Subject | Related Preparation |
| 1) | Why companies are bought or sold? | |
| 2) | Why the industry in which the company operates is important? Hence industry analysis | |
| 3) | What make the medium and small companies differ from the big ones | |
| 5) | Valuation II | |
| 5) | What are the value drivers of a company? | |
| 6) | Valuation II | |
| 7) | Most used valuation techniques | |
| 8) | Other valuation techniques | |
| 9) | M&A process | |
| 10) | M&A milestones | |
| 11) | Negotiation I | |
| 12) | Negotiation II | |
| 13) | Due diligence | |
| 14) | Wrap up |
| Course Notes / Textbooks: | Mergers & Acquisitions ,A. Sherman and Milledge Hart (2006), Investment Valuation, Aswath Damodaran (2002) |
| References: | Yok / None |
| Semester Requirements | Number of Activities | Level of Contribution |
| Homework Assignments | 1 | % 20 |
| Midterms | 1 | % 35 |
| Final | 1 | % 45 |
| Total | % 100 | |
| PERCENTAGE OF SEMESTER WORK | % 55 | |
| PERCENTAGE OF FINAL WORK | % 45 | |
| Total | % 100 | |
| Activities | Number of Activities | Duration (Hours) | Workload |
| Course Hours | 14 | 3 | 42 |
| Study Hours Out of Class | 14 | 4 | 56 |
| Homework Assignments | 1 | 35 | 35 |
| Midterms | 1 | 40 | 40 |
| Final | 1 | 45 | 45 |
| Total Workload | 218 | ||
| No Effect | 1 Lowest | 2 Low | 3 Average | 4 High | 5 Highest |
| Program Outcomes | Level of Contribution | |
| 1) | Adequate knowledge of subjects specific to mathematics (analysis, linear, algebra, differential equations, statistics), science (physics, chemistry, biology) and related engineering discipline, and the ability to use theoretical and applied knowledge in these fields in complex engineering problems. | |
| 2) | Identify, formulate, and solve complex Biomedical Engineering problems; select and apply proper modeling and analysis methods for this purpose | |
| 3) | Design complex Biomedical systems, processes, devices or products under realistic constraints and conditions, in such a way as to meet the desired result; apply modern design methods for this purpose. | |
| 4) | Devise, select, and use modern techniques and tools needed for solving complex problems in Biomedical Engineering practice; employ information technologies effectively. | |
| 5) | Design and conduct numerical or physical experiments, collect data, analyze and interpret results for investigating the complex problems specific to Biomedical Engineering. | |
| 6) | Cooperate efficiently in intra-disciplinary and multi-disciplinary teams; and show self-reliance when working on Biomedical Engineering-related problems. | |
| 7) | Ability to communicate effectively in Turkish, oral and written, to have gained the level of English language knowledge (European Language Portfolio B1 general level) to follow the innovations in the field of Biomedical Engineering; gain the ability to write and understand written reports effectively, to prepare design and production reports, to make effective presentations, to give and receive clear and understandable instructions. | |
| 8) | Recognize the need for life-long learning; show ability to access information, to follow developments in science and technology, and to continuously educate oneself. | |
| 9) | Having knowledge for the importance of acting in accordance with the ethical principles of biomedical engineering and the awareness of professional responsibility and ethical responsibility and the standards used in biomedical engineering applications | |
| 10) | Learn about business life practices such as project management, risk management, and change management; develop an awareness of entrepreneurship, innovation, and sustainable development. | |
| 11) | Acquire knowledge about the effects of practices of Biomedical Engineering on health, environment, security in universal and social scope, and the contemporary problems of Biomedical Engineering; is aware of the legal consequences of Mechatronics engineering solutions. |